Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-23-011180
Filing Date
2023-12-13
Accepted
2023-12-13 17:14:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 20819
2 GRAPHIC g530411gra001.jpg GRAPHIC 5579
  Complete submission text file 0000950123-23-011180.txt   29619
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)